Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,465,000 | 10,967,000 | 4,074,000 | 3,453,000 | 3,503,000 |
| Marketable Securities | 67,000 | 3,010,000 | 61,000 | 61,000 | 59,000 |
| Inventories | 4,664,000 | 6,003,000 | 5,783,000 | 6,244,000 | 6,330,000 |
| Other current assets | 42,992,000 | 9,008,000 | 8,441,000 | 8,496,000 | 7,674,000 |
| TOTAL | $54,188,000 | $28,988,000 | $18,674,000 | $18,254,000 | $17,566,000 |
| Non-Current Assets | |||||
| PPE Net | 9,153,000 | 10,704,000 | 10,672,000 | 10,667,000 | 10,589,000 |
| Intangibles | 17,277,000 | 41,173,000 | 40,631,000 | 40,823,000 | 39,768,000 |
| Other Non-Current Assets | 8,427,000 | 8,824,000 | 9,126,000 | 8,945,000 | 9,088,000 |
| TOTAL | $34,857,000 | $60,701,000 | $60,429,000 | $60,435,000 | $59,445,000 |
| Total Assets | $89,045,000 | $89,689,000 | $79,103,000 | $78,689,000 | $77,011,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 3,398,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 14,806,000 | 17,577,000 | 4,535,000 | 15,230,000 | 14,267,000 |
| Other current liabilities | 888,000 | 971,000 | 958,000 | 765,000 | 743,000 |
| TOTAL | $37,835,000 | $24,278,000 | $23,670,000 | $22,417,000 | $21,387,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 19,760,000 | N/A | N/A |
| Other Non-Current Liabilities | 22,155,000 | 32,660,000 | 3,591,000 | 24,536,000 | 24,258,000 |
| TOTAL | $28,570,000 | $42,779,000 | $34,091,000 | $34,524,000 | $34,046,000 |
| Total Liabilities | $66,405,000 | $67,057,000 | $57,761,000 | $56,941,000 | $55,433,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,347,000 | 1,347,000 | 1,347,000 | 1,347,000 | 1,347,000 |
| Retained earnings | 9,824,000 | 9,637,000 | 7,944,000 | 7,783,000 | 7,379,000 |
| Other shareholders' equity | 1,764,000 | 1,761,000 | 2,463,000 | 2,996,000 | 3,352,000 |
| TOTAL | $16,374,000 | $16,181,000 | $15,055,000 | $15,426,000 | $15,377,000 |
| Total Liabilities And Equity | $82,779,000 | $83,238,000 | $72,816,000 | $72,367,000 | $70,810,000 |